← Mechanisms of action
ERBB3
SINGLE PROTEINHomo sapiens
Preferred name: Receptor tyrosine-protein kinase erbB-3 ChEMBL ↗
Linked proteins
Drugs acting on this target (42)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| ak138d1 | Antagonist | experimental | Small molecule | ERBB3 antagonist |
| BL-B01D1 | Antagonist | experimental | mAb | ERBB3 antagonist |
| hmbd-001 | Antagonist | experimental | mAb | ERBB3 antagonist |
| seribantumab | Antagonist | experimental | mAb | ERBB3 antagonist |
| patritumab | Binding agent | experimental | mAb | Receptor tyrosine-protein kinase erbB-3 binding agent |
| yl202 | Binding agent | experimental | mAb | ERBB3 binding agent |
| anti-her2/her3 dendritic cell vaccine | Immunity, active | experimental | Vaccine | ERBB3 immunity, active |
| her3 - primed dendritic cells | Immunity, active | experimental | Vaccine | ERBB3 immunity, active |
| ping-hher3fl | Immunity, active | experimental | Vaccine | ERBB3 immunity, active |
| 89zr-gsk2849330 | Immunity, passive | experimental | mAb | ERBB3 immunity, passive |
| sibp-03 | Immunity, passive | experimental | mAb | ERBB3 immunity, passive |
| amt-562 | Inhibitor | experimental | mAb | ERBB3 inhibitor |
| av-203 | Inhibitor | experimental | mAb | ERBB3 inhibitor |
| avzo-1418 | Inhibitor | experimental | mAb | ERBB3 inhibitor |
| b001 | Inhibitor | experimental | mAb | ERBB3 inhibitor |
| bl-b16d1 | Inhibitor | experimental | mAb | ERBB3 inhibitor |
| cdx-3379 | Inhibitor | experimental | mAb | Receptor tyrosine-protein kinase erbB-3 inhibitor |
| db-1310 | Inhibitor | experimental | mAb | ERBB3 inhibitor |
| dm002 | Inhibitor | experimental | mAb | ERBB3 inhibitor |
| duligotuzumab | Inhibitor | experimental | mAb | ERBB3 inhibitor |
| env-501 | Inhibitor | experimental | mAb | ERBB3 inhibitor |
| gsk2849330 | Inhibitor | experimental | mAb | ERBB3 inhibitor |
| isu104 | Inhibitor | experimental | mAb | ERBB3 inhibitor |
| js212 | Inhibitor | experimental | mAb | ERBB3 inhibitor |
| ktn3379 | Inhibitor | experimental | mAb | ERBB3 inhibitor |
| ljm716 | Inhibitor | experimental | mAb | ERBB3 inhibitor |
| mm-111 | Inhibitor | experimental | mAb | ERBB3 inhibitor |
| mm-141 | Inhibitor | experimental | mAb | ERBB3 inhibitor |
| patritumab | Inhibitor | experimental | mAb | ERBB3 inhibitor |
| pyrrolitinib | Inhibitor | experimental | Small molecule | ERBB3 inhibitor |
| regn1400 | Inhibitor | experimental | mAb | ERBB3 inhibitor |
| rg-7116 | Inhibitor | experimental | mAb | ERBB3 inhibitor |
| ro5479599 | Inhibitor | experimental | mAb | ERBB3 inhibitor |
| sapitinib | Inhibitor | experimental | Small molecule | ERBB3 inhibitor |
| seribantumab | Inhibitor | experimental | mAb | ERBB3 inhibitor |
| si-b001 | Inhibitor | experimental | mAb | ERBB3 inhibitor |
| sibp-a13 | Inhibitor | experimental | Small molecule | ERBB3 inhibitor |
| sym013 | Inhibitor | experimental | mAb | ERBB3 inhibitor |
| sys6023 | Inhibitor | experimental | mAb | ERBB3 inhibitor |
| u3-1402 | Inhibitor | experimental | mAb | ERBB3 inhibitor |
| zenocutuzumab (Bizengri) | Inhibitor | approved | mAb | ERBB3 inhibitor |
| zr89 ro5479599 | Inhibitor | experimental | mAb | ERBB3 inhibitor |